comparemela.com

Latest Breaking News On - Hillman solns - Page 1 : comparemela.com

4 Analysts Assess Hillman Solns: What You Need To Know

Throughout the last three months, 4 analysts have evaluated Hillman Solns (NASDAQ:HLMN), offering a diverse set of opinions from bullish to bearis.

Canada
United-states
Mexico
America
Matthew-bouley
Canaccord-genuity
Hillman-solns
Brian-mcnamara
Michael-hoffman
Hillman-solutions-corp
Analyst-firm
Digital-solutions

Earnings Scheduled For February 22, 2024 - Kymera Therapeutics (NASDAQ:KYMR), Loews (NYSE:L)

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

United-states
American
Liberty-latin-america
Hillman-solns
Banco-latinoamericano
Amylyx-pharma
Maravai-lifesciences
Health-catalyst
Grid-dynamics-holdings
Wisdomtree-emerging-markets-local-debt-fund
Rhythm-pharmaceuticals
Noble-corp

The Latest Analyst Ratings for Hillman Solns - Hillman Solns (NASDAQ:HLMN)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.